Several mutations in the EGFR gene have been identified. The most common mutations in NSCLC are deletions in exon 19 and the L858R point mutation in exon 21. These mutations lead to constitutive activation of the receptor, even in the absence of ligand binding, driving continuous cell proliferation and survival.
